Research
Research That Shapes the Future of Women’s Health
Our clinical research program focuses on new areas of treatment for which there has been little or no pharmaceutical investigation and where existing preparations have short-comings. Many conditions such as post natal depression, endometriosis, female androgen deficiency including female sexual dysfunction (FSD), male androgen deficiency and polycystic ovarian syndrome have underlying states of hormonal imbalance.
RECRUITING NOW: Testosterone for Low Sexual Desire in Premenopausal Women: The Sybil Study
A randomised controlled trial evaluating whether testosterone therapy can improve low sexual desire in premenopausal women.
Active Trial:
Recruitment Phase – Melbourne
Monash – A study to prevent bone loss and restore sexual function in women after menopause
A multi-centre randomised controlled trial evaluating whether testosterone therapy can improve libido and prevent bone loss in postmenopausal women.
Recruitment Completed:
Expected Published Data: Q2 2026
Monash – Prevention of Muscle Loss After Menopause Using Testosterone: The PAMELA Study
A randomised controlled trial evaluating whether testosterone therapy can prevent muscle and bone loss after menopause.
Recruitment Completed:
Expected Published Data: Q2 2026
Monash - Evaluating Testosterone Therapy to Prevent Early Heart Failure in Women: The ETHEL study
A randomised controlled trial evaluating whether testosterone therapy can prevent early changes in the heart from progressing to heart failure in postmenopausal women. This study is being conducted in conjunction with the Baker Heart and Diabetes Institute and supported by a National Heart Foundation Vanguard Grant.
Recruitment Completed:
Expected Published Data: Q2 2026